Global Anti-obesity Medicine Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 07-Apr-2021
No. of pages: 107
Inquire Before Buying

Global Anti-obesity Medicine Scope and Market Size

Anti-obesity Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-obesity Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Prescription Drugs

- OTC Drugs

Segment by Application

- Men

- Women

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Alizyme

- Amylin Pharmaceuticals

- Arena Pharmaceuticals

- Boehringer Ingelheim

- Eisai

- GlaxoSmithKline

- Orexigen Therapeutics

- Vivus

- Pfizer

- Roche

- Merck

- Novo Nordisk

Global Anti-obesity Medicine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Anti-obesity Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-obesity Medicine Market Perspective (2016-2027)
2.2 Anti-obesity Medicine Growth Trends by Regions
2.2.1 Anti-obesity Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-obesity Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Anti-obesity Medicine Industry Dynamic
2.3.1 Anti-obesity Medicine Market Trends
2.3.2 Anti-obesity Medicine Market Drivers
2.3.3 Anti-obesity Medicine Market Challenges
2.3.4 Anti-obesity Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-obesity Medicine Players by Revenue
3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2016-2021)
3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
3.4 Global Anti-obesity Medicine Market Concentration Ratio
3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2020
3.5 Anti-obesity Medicine Key Players Head office and Area Served
3.6 Key Players Anti-obesity Medicine Product Solution and Service
3.7 Date of Enter into Anti-obesity Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-obesity Medicine Breakdown Data by Type
4.1 Global Anti-obesity Medicine Historic Market Size by Type (2016-2021)
4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027)
5 Anti-obesity Medicine Breakdown Data by Application
5.1 Global Anti-obesity Medicine Historic Market Size by Application (2016-2021)
5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-obesity Medicine Market Size (2016-2027)
6.2 North America Anti-obesity Medicine Market Size by Type
6.2.1 North America Anti-obesity Medicine Market Size by Type (2016-2021)
6.2.2 North America Anti-obesity Medicine Market Size by Type (2022-2027)
6.2.3 North America Anti-obesity Medicine Market Size by Type (2016-2027)
6.3 North America Anti-obesity Medicine Market Size by Application
6.3.1 North America Anti-obesity Medicine Market Size by Application (2016-2021)
6.3.2 North America Anti-obesity Medicine Market Size by Application (2022-2027)
6.3.3 North America Anti-obesity Medicine Market Size by Application (2016-2027)
6.4 North America Anti-obesity Medicine Market Size by Country
6.4.1 North America Anti-obesity Medicine Market Size by Country (2016-2021)
6.4.2 North America Anti-obesity Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-obesity Medicine Market Size (2016-2027)
7.2 Europe Anti-obesity Medicine Market Size by Type
7.2.1 Europe Anti-obesity Medicine Market Size by Type (2016-2021)
7.2.2 Europe Anti-obesity Medicine Market Size by Type (2022-2027)
7.2.3 Europe Anti-obesity Medicine Market Size by Type (2016-2027)
7.3 Europe Anti-obesity Medicine Market Size by Application
7.3.1 Europe Anti-obesity Medicine Market Size by Application (2016-2021)
7.3.2 Europe Anti-obesity Medicine Market Size by Application (2022-2027)
7.3.3 Europe Anti-obesity Medicine Market Size by Application (2016-2027)
7.4 Europe Anti-obesity Medicine Market Size by Country
7.4.1 Europe Anti-obesity Medicine Market Size by Country (2016-2021)
7.4.2 Europe Anti-obesity Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-obesity Medicine Market Size (2016-2027)
8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type
8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application
8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region
8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-obesity Medicine Market Size (2016-2027)
9.2 Latin America Anti-obesity Medicine Market Size by Type
9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Anti-obesity Medicine Market Size by Type (2016-2027)
9.3 Latin America Anti-obesity Medicine Market Size by Application
9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Anti-obesity Medicine Market Size by Application (2016-2027)
9.4 Latin America Anti-obesity Medicine Market Size by Country
9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-obesity Medicine Market Size (2016-2027)
10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type
10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application
10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country
10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alizyme
11.1.1 Alizyme Company Details
11.1.2 Alizyme Business Overview
11.1.3 Alizyme Anti-obesity Medicine Introduction
11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2016-2021)
11.1.5 Alizyme Recent Development
11.2 Amylin Pharmaceuticals
11.2.1 Amylin Pharmaceuticals Company Details
11.2.2 Amylin Pharmaceuticals Business Overview
11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.2.5 Amylin Pharmaceuticals Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Details
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Anti-obesity Medicine Introduction
11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Company Details
11.7.2 Orexigen Therapeutics Business Overview
11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021)
11.7.5 Orexigen Therapeutics Recent Development
11.8 Vivus
11.8.1 Vivus Company Details
11.8.2 Vivus Business Overview
11.8.3 Vivus Anti-obesity Medicine Introduction
11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2016-2021)
11.8.5 Vivus Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-obesity Medicine Introduction
11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Anti-obesity Medicine Introduction
11.10.4 Roche Revenue in Anti-obesity Medicine Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Anti-obesity Medicine Introduction
11.11.4 Merck Revenue in Anti-obesity Medicine Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021)
11.12.5 Novo Nordisk Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti-obesity Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-obesity Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anti-obesity Medicine Market Share by Regions (2016-2021)
Table 8. Global Anti-obesity Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Table 10. Anti-obesity Medicine Market Trends
Table 11. Anti-obesity Medicine Market Drivers
Table 12. Anti-obesity Medicine Market Challenges
Table 13. Anti-obesity Medicine Market Restraints
Table 14. Global Anti-obesity Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anti-obesity Medicine Market Share by Players (2016-2021)
Table 16. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020)
Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-obesity Medicine Product Solution and Service
Table 21. Date of Enter into Anti-obesity Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anti-obesity Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anti-obesity Medicine Revenue Market Share by Application (2016-2021)
Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anti-obesity Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-obesity Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anti-obesity Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anti-obesity Medicine Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anti-obesity Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti-obesity Medicine Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti-obesity Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-obesity Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anti-obesity Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Alizyme Company Details
Table 62. Alizyme Business Overview
Table 63. Alizyme Anti-obesity Medicine Product
Table 64. Alizyme Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 65. Alizyme Recent Development
Table 66. Amylin Pharmaceuticals Company Details
Table 67. Amylin Pharmaceuticals Business Overview
Table 68. Amylin Pharmaceuticals Anti-obesity Medicine Product
Table 69. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 70. Amylin Pharmaceuticals Recent Development
Table 71. Arena Pharmaceuticals Company Details
Table 72. Arena Pharmaceuticals Business Overview
Table 73. Arena Pharmaceuticals Anti-obesity Medicine Product
Table 74. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 75. Arena Pharmaceuticals Recent Development
Table 76. Boehringer Ingelheim Company Details
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Anti-obesity Medicine Product
Table 79. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 80. Boehringer Ingelheim Recent Development
Table 81. Eisai Company Details
Table 82. Eisai Business Overview
Table 83. Eisai Anti-obesity Medicine Product
Table 84. Eisai Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Anti-obesity Medicine Product
Table 89. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Orexigen Therapeutics Company Details
Table 92. Orexigen Therapeutics Business Overview
Table 93. Orexigen Therapeutics Anti-obesity Medicine Product
Table 94. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 95. Orexigen Therapeutics Recent Development
Table 96. Vivus Company Details
Table 97. Vivus Business Overview
Table 98. Vivus Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 99. Vivus Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Anti-obesity Medicine Product
Table 103. Pfizer Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 104. Pfizer Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Anti-obesity Medicine Product
Table 108. Roche Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Anti-obesity Medicine Product
Table 113. Merck Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 114. Merck Recent Development
Table 115. Novo Nordisk Company Details
Table 116. Novo Nordisk Business Overview
Table 117. Novo Nordisk Anti-obesity Medicine Product
Table 118. Novo Nordisk Revenue in Anti-obesity Medicine Business (2016-2021) & (US$ Million)
Table 119. Novo Nordisk Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-obesity Medicine Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drugs Features
Figure 3. OTC Drugs Features
Figure 4. Global Anti-obesity Medicine Market Share by Application: 2020 VS 2027
Figure 5. Men Case Studies
Figure 6. Women Case Studies
Figure 7. Anti-obesity Medicine Report Years Considered
Figure 8. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Anti-obesity Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-obesity Medicine Market Share by Regions: 2020 VS 2027
Figure 11. Global Anti-obesity Medicine Market Share by Regions (2022-2027)
Figure 12. Global Anti-obesity Medicine Market Share by Players in 2020
Figure 13. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-obesity Medicine as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2020
Figure 15. Global Anti-obesity Medicine Revenue Market Share by Type (2016-2021)
Figure 16. Global Anti-obesity Medicine Revenue Market Share by Type (2022-2027)
Figure 17. North America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 19. North America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 20. North America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 21. United States Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 25. Europe Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 26. Europe Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 27. Germany Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Anti-obesity Medicine Market Share by Region (2016-2027)
Figure 37. China Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 45. Latin America Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 46. Latin America Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 47. Mexico Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anti-obesity Medicine Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Anti-obesity Medicine Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Anti-obesity Medicine Market Share by Country (2016-2027)
Figure 53. Turkey Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Anti-obesity Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 57. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 58. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 60. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 62. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 63. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global Testosterone Booster Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 125
    The global Testosterone Booster market is segmented by company, region (country), by Type, and by User. Players, stakeholders, and other participants in the global Testosterone Booster market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by User for the period 2016-2027. Segment by Type - D Aspartic Acid - Vitamin D3 - Other......
  • Global Whey Protein Isolate Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 120
    The global Whey Protein Isolate market is segmented by company, region (country), by Grade, and by Application. Players, stakeholders, and other participants in the global Whey Protein Isolate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Grade and by Application for the period 2016-2027. Segment by Grade - Food Grade Whey Protein Isolate ......
  • Global Pantoprazole Sodium Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 125
    The global Pantoprazole Sodium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pantoprazole Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Delayed-Release Tablets - Injection......
  • Global Digestive Health Products Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 134
    The global Digestive Health Products market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digestive Health Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Dairy Products - Bakery P......
  • Global Oral Rehydration Salts Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 144
    The global Oral Rehydration Salts market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Rehydration Salts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Tablets Oral Rehydration Salts ......
  • Global Mannan-Oligosaccharide Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 116
    The global Mannan-Oligosaccharide market is segmented by company, region (country), by Grade, and by Application. Players, stakeholders, and other participants in the global Mannan-Oligosaccharide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Grade and by Application for the period 2016-2027. Segment by Grade - Food Grade Mannan-Oligosaccharide......
  • Global Polymyxins Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 131
    The global Polymyxins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polymyxins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Injection Polymyxins - External Polymyxins ......
  • Global Chondroitin and Hyaluronic Acid (Sodium + Injection) Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 121
    The global Chondroitin and Hyaluronic Acid (Sodium + Injection) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chondroitin and Hyaluronic Acid (Sodium + Injection) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Seg......
  • Global Avanafil Sales Market Report 2021
    Published: 20-Apr-2021        Price: US 4000 Onwards        Pages: 115
    The global Avanafil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Avanafil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 50 mg Avanafil - 100 mg Avanafil - 200 mg Avanafil......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs